You are here: Industry Insights > UroGen

News List

UroGen’s urothelial cancer drug hits target, could prevent surgery pharmaphorum
January 10, 2019
Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead drug could change standard of care in a form of urothelial cancer.
UroGen appoints former Novartis cancer chief Barrett as CEO pharmaphorum
January 09, 2019
Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring its potential urothelial cancer drug to market.
Ex-Novartis Oncology CEO Liz Barrett joins UroGen fiercebiotech
January 04, 2019
Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking over as CEO of the uro-oncology specialist at a time when it is working on a rolling NDA that could lead to its first drug approval.....
Deals this week: ContraVir Pharmaceuticals, UroGen Pharmaceuticals, Fresenius pharmaceutical-technology
April 28, 2017
US-based ContraVir Pharmaceuticals will issue shares of its common stock and warrants to purchase shares in order to...